To evaluate whether the
experimental treatment is safe and whether it might be able to reduce frailty, Maharaj plans to
run a battery of baseline testing on each clinical trial participant before they get their first infusion of young plasma and then monitor their changes for two years: That means cognitive exams, questionnaires about their
quality of life and their indicators of frailty, and tests to measure biomarkers he believes are linked with aging, such as telomere lengths and DNA methylation.
They also
run Urban Digital Printing out of their space, which has become the go to destination for high
quality digital printing as well as
experimental digital printing techniques.